Lyra Therapeutics' Spinoff / Spinout Round

Lyra Therapeutics raised a round of funding on October 26, 2011. Investors include Arsenal Medical.

Lyra Therapeutics, fka 480 Biomedical, is a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, offering an alternative to conve…

Articles about Lyra Therapeutics' Spinoff / Spinout Round: